Fri, Apr 26, 2024
[Archive]
Volume 7, Issue 4 (NOV 2022)
JNFS 2022, 7(4): 562-574 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Yaghoubi F, Darabi Z, Ahmadi Vasmehjani A, Sangsefidi Z S, Hosseinzadeh M. The Effect of Dark Chocolate on C-Reactive Protein Level: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. JNFS 2022; 7 (4) :562-574
URL: http://jnfs.ssu.ac.ir/article-1-531-en.html
URL: http://jnfs.ssu.ac.ir/article-1-531-en.html
Fatemeh Yaghoubi 
, Zahra Darabi , Azam Ahmadi Vasmehjani , Zohreh Sadat Sangsefidi , Mahdieh Hosseinzadeh *
, Zahra Darabi , Azam Ahmadi Vasmehjani , Zohreh Sadat Sangsefidi , Mahdieh Hosseinzadeh *
Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract: (1250 Views)
Background: This systematic review and meta‐analysis of randomized controlled trials (RCTs) was conducted to determine the effect of dark chocolate on C-Reactive Protein (CRP) levels as one of the inflammatory factors. Methods: A literature search was conducted in PubMed, ISI Web of Science, Scopus, and Google Scholar up to April of 2020. The registration number of study in PROSPERO was CRD4202020072, which was conducted over 5 eligible RCTs containing a total of 330 participants. The weighted mean difference (WMD) with 95% confidence intervals was calculated for the pool effect size of CRP. The heterogeneity of studies was examined by Cochran's Q test and I-squared (I2) statistic. Results: Effect sizes from 330 participants based on random effect model showed no effect between consumption of dark chocolate on CRP levels compared to the control group (WMD: 0.01 mg/dl; 95% CI: −0.19, 0.22 mg/dl; P = 0.89; Cochran's Q test, Q statistic = 21.97; P < 0.001; I2 = 81.80%). The results of subgroup analysis based on intervention duration and dosage showed no significant effect on CRP levels (WMD = 0.05 mg/dl, 95% CI: −0.30, 0.42 mg/dl; P = 0.76). Meta-regression for the intervention duration (slope: −0.0033, 95% CI: −0.0089, 0.0022; P = 0.24) and dosage (slope: 0.00006, 95% CI: −0.0036, 0.0037; P = 0.97) indicated no significant relationship with the mean difference of CRP. Conclusion: The results of the present meta-analysis showed that consuming dark chocolate had no significant effect on the CRP level. More clinical trials are required with higher quality and bigger sample sizes to verify the positive impact of dark chocolate on the reduction CRP level.
Type of article: review article |
Subject:
public specific
Received: 2021/12/2 | Published: 2022/11/19 | ePublished: 2022/11/19
Received: 2021/12/2 | Published: 2022/11/19 | ePublished: 2022/11/19
References
1. Borenstein M, Hedges LV, Higgins JP & Rothstein HR 2011. Introduction to meta-analysis. John Wiley & Sons.
2. Cao G, Sofic E & Prior RL 1997. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free radical biology and medicine. 22 (5): 749-760.
3. Cottone S, et al. 2006. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. American journal of hypertension. 19 (3): 313-318.
4. da Costa Teixeira AMN, et al. 2017. The impact of dark chocolate intake on arterial elasticity in individuals with HIV/AIDS undergoing ART: a randomized, double-blind, crossover trial. Food & function. 8 (6): 2212-2219.
5. Desch S, et al. 2010. Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. American journal of hypertension. 23 (6): 694-700.
6. Di Giuseppe R, et al. 2008. Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population. Journal of nutrition. 138 (10): 1939-1945.
7. Di Renzo L, et al. 2013. Effects of dark chocolate in a population of normal weight obese women: a pilot study. European review for medical
9. and pharmacological sciences. 17 (16): 2257-2266.
10. Duval S & Tweedie R 2000. Trim and fill: a simple funnel‐plot–based method of testing and adjusting for publication bias in meta‐analysis. Biometrics. 56 (2): 455-463.
11. Fernández-Real JM & Ricart W 2003. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine reviews. 24 (3): 278-301.
12. Grassi D, et al. 2008. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. Journal of nutrition. 138 (9): 1671-1676.
13. Grassi D, et al. 2005. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 46 (2): 398-405.
14. Haber SL & Gallus K 2012. Effects of dark chocolate on blood pressure in patients with hypertension. American journal of health-system pharmacy. 69 (15): 1287-1288, 1290, 1292-1283.
15. Haghighat N, et al. 2013. The effects of dark chocolate on lipid profile, apo-lipoprotein A-1, apo-lipoprotein B and inflammation in type-2 diabetic patients: A randomized clinical trial. Iranian journal of nutrition sciences & food technology. 8 (2): 21-30.
16. Hamed MS, et al. 2008. Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. Southern medical journal. 101 (12): 1203-1208.
17. Higgins J 2011. GSE Cochrane Handbook for Systematic Systematic Reviews of Interventions Version 5.1. 0.
18. Higgins J, et al. 2019. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons.
19. Higgins J & Thompson SG 2002. Quantifying heterogeneity in a meta‐analysis. Statistics in medicine. 21 (11): 1539-1558.
20. Hooper L, et al. 2012. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. American journal of clinical nutrition. 95 (3): 740-751.
21. Hotamisligil GS 2010. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 140 (6): 900-917.
22. Hotamisligil GS, Shargill NS & Spiegelman BM 1993. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259 (5091): 87-91.
23. Jafarirad S, et al. 2018. Dark chocolate effect on serum adiponectin, biochemical and inflammatory parameters in diabetic patients: A randomized clinical trial. International journal of preventive medicine. 9.
24. Javadi F, et al. 2017. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial. Journal of the American college of nutrition. 36 (1): 9-15.
25. Jia L, et al. 2010. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. American journal of clinical of nutrition. 92: 218-225.
26. Kord-Varkaneh H, Ghaedi E, Nazary-Vanani A, Mohammadi H & Shab-Bidar S 2019. Does cocoa/dark chocolate supplementation have favorable effect on body weight, body mass index and waist circumference? A systematic review, meta-analysis and dose-response of randomized clinical trials. Critical reviews in food science and nutrition. 59 (15): 2349-2362.
27. Kuebler U, et al. 2016. Dark chocolate attenuates intracellular pro-inflammatory reactivity to acute psychosocial stress in men: A randomized controlled trial. Brain, behavior, and immunity. 57: 200-208.
28. Kurlandsky SB & Stote KS 2006. Cardioprotective effects of chocolate and almond consumption in healthy women. Nutrition research. 26 (10): 509-516.
29. Libby P 2007. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutrition reviews. 65 (12 Pt 2): S140-146.
30. Magrone T, Russo MA & Jirillo E 2017. Cocoa and dark chocolate polyphenols: from biology to clinical applications. Frontiers in immunology. 8: 677.
31. Malhi H & Loomba R 2016. Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress. Alimentary pharmacology & therapeutics. 44 (5): 533-534.
32. Mao T, et al. 2000. Effect of cocoa procyanidins on the secretion of interleukin-4 in peripheral blood mononuclear cells. Journal of medicinal food. 3 (2): 107-114.
33. Mao T, Water JVD, Keen C, Schmitz H & Gershwin M 2003. Cocoa Flavonols and Procyanidins Promote Transforming Growth Factor-β1 Homeostasis in Peripheral Blood Mononuclear Cells1. Experimental biology and medicine. 228 (1): 93-99.
34. Mehrabani S, Arab A, Mohammadi H & Amani R 2020. The effect of cocoa consumption on markers of oxidative stress: A systematic review and meta-analysis of interventional studies. Complementary therapies in medicine. 48: 102240.
35. Mizuno Y, Jacob RF & Mason RP 2011. Inflammation and the development of atherosclerosis: effects of lipid-lowering therapy. Journal of atherosclerosis and thrombosis. 1103160359-1103160359.
36. Moher D, et al. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic review. 4 (1): 1.
37. Montagna MT, et al. 2019. Chocolate,“food of the gods”: History, science, and human health. International journal of environmental research and public health. 16 (24): 4960.
38. Nahrendorf M & Swirski FK 2015. Neutrophil-macrophage communication in inflammation and atherosclerosis. Science. 349 (6245): 237-238.
39. Nanetti L, et al. 2012. Effect of consumption of dark chocolate on oxidative stress in lipoproteins and platelets in women and in men. Appetite. 58 (1): 400-405.
40. Nanetti L, et al. 2008. Effect of consumption of dark chocolate on lipoproteins and serum lipids. Mediterranean journal of nutrition and metabolism. 1 (1): 25.
41. Ramiro E, et al. 2005. Flavonoids from Theobroma cacao down-regulate inflammatory mediators. Journal of agricultural and food chemistry. 53 (22): 8506-8511.
42. Rezazadeh A, Mahmoodi M, Mard SA & karimi Moghaddam E 2015. The effects of dark chocolate consumption on lipid profile, fasting blood sugar, liver enzymes, inflammation, and antioxidant status in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled, pilot study. Journal of gastroenterology and hepatology research. 4 (12): 1858-1864.
43. Sanbongi C, Suzuki N & Sakane T 1997. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humansin vitro. Cellular immunology. 177 (2): 129-136.
44. Sangsefidi ZS, Yaghoubi F, Hajiahmadi S & Hosseinzadeh M 2020. The effect of coenzyme Q10 supplementation on oxidative stress: A systematic review and meta‐analysis of randomized controlled clinical trials. Food science & nutrition. 8 (4): 1766-1776.
45. Selmi C, Cocchi CA, Lanfredini M, Keen CL & Gershwin ME 2008. Chocolate at heart: The anti‐inflammatory impact of cocoa flavanols. Molecular nutrition & food research. 52 (11): 1340-1348.
46. Sudarma V, Sukmaniah S & Siregar P 2011. Effect of dark chocolate on nitric oxide serum levels and blood pressure in prehypertension subjects. Acta medica Indonesiana. 43 (4): 224-228.
47. Tlaskalová-Hogenová H, et al. 2011. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cellular & molecular immunology. 8 (2): 110-120.
48. Wellen KE & Hotamisligil GS 2005. Inflammation, stress, and diabetes. Journal of clinical investigation. 115 (5): 1111-1119.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
